Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07229846
What this trial is testing

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

Who this might be right for
Colorectal Cancer
Yanqiao Zhang 30
Testing effectiveness (Phase 2)Study completedNCT03721653
What this trial is testing

FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 218
Testing effectiveness (Phase 2)UnknownNCT05160896
What this trial is testing

SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer

Who this might be right for
Advanced Metastatic Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05652894
What this trial is testing

HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD 190
Large-scale testing (Phase 3)Study completedNCT00101686
What this trial is testing

Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.

Who this might be right for
Colorectal Neoplasms
Pfizer 547
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621497
What this trial is testing

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Sun Yat-sen University 229
Testing effectiveness (Phase 2)UnknownNCT03751176
What this trial is testing

Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal

Who this might be right for
Colorectal Cancer Metastatic
Grupo Espanol Multidisciplinario del Cancer Digestivo 31
Testing effectiveness (Phase 2)WithdrawnNCT00988897
What this trial is testing

Colorectal Cancer RECHALLENGE

Who this might be right for
Colorectal Neoplasms
Sanofi
Testing effectiveness (Phase 2)UnknownNCT02476045
What this trial is testing

Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino)

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 224
Not applicableUnknownNCT01363739
What this trial is testing

Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 265
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06665087
What this trial is testing

CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC

Who this might be right for
Colon CancerRectal Cancer
Fudan University 110
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Large-scale testing (Phase 3)UnknownNCT00021281
What this trial is testing

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06245356
What this trial is testing

Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Gastroesophageal AdenocarcinomaDPD Deficiency
UNICANCER 73
Not applicableStudy completedNCT02305615
What this trial is testing

An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07622550
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 80
Large-scale testing (Phase 3)Study completedNCT01030042
What this trial is testing

Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 110
Testing effectiveness (Phase 2)Study completedNCT00254137
What this trial is testing

Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Ludwig-Maximilians - University of Munich 92
Not applicableStudy completedNCT04317599
What this trial is testing

A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

Who this might be right for
BRAF V600E Mutation PositiveMetastatic Colorectal Cancer
Pierre Fabre Medicament 274
Testing effectiveness (Phase 2)Ended earlyNCT02045030
What this trial is testing

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
CR-CSSS Champlain-Charles-Le Moyne 14
Next Page